Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: an observational multicentric study in 443 patients with melanoma.
E NagoreMiguel Ángel Martínez-GarcíaJ D Gomez-OlivasE Manrique-SilvaA MartorellJ BañulsC CarreraP OrtizJ GardeazabalA BoadaE de EusebioE ChinerC GonzalezA Pérez-GilD CullenM FormigónB de UnamunoC Navarro-SorianoA MurielD GozalPublished in: The British journal of dermatology (2021)
T2DM, rather than glycaemic control and metformin treatment, is associated with increased cutaneous melanoma aggressiveness at diagnosis.